-+ 0.00%
-+ 0.00%
-+ 0.00%

Chardan Capital Upgrades Kodiak Sciences to Buy, Raises Price Target to $61

Benzinga·05/11/2026 12:11:14
Listen to the news
Chardan Capital analyst Daniil Gataulin upgrades Kodiak Sciences (NASDAQ:KOD) from Neutral to Buy and raises the price target from $14 to $61.